CytomX Therapeutics Inc (CTMX) support and resistance · rev $138.1M
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
This page maps CytomX Therapeutics Inc (CTMX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
CTMX currently screens at market cap $653.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CTMX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CTMX quote page for the session range and the stock page for the full model.
Not investment advice.